Literature DB >> 9009957

Neural blockade for diagnosis and prognosis. A review.

Q H Hogan1, S E Abram.   

Abstract

On the basis of the published material reviewed above, we conclude that there are many limitations that weaken the theoretic basis for neural blockade as a diagnostic or prognostic tool. In addition, these procedures in general lack thorough documentation of clinical usefulness. Reasonable employment of diagnostic neural blockade, therefore, requires not only care in technique and confirmation of effects, but also caution in interpretation and application of the results. This critical evaluation needs to be tempered, however, by two further observations. Experienced and observant clinicians have found these procedures may, on certain occasions, provide information that is helpful in guiding subsequent therapy, so we should not be in haste to dismiss the accumulated judgment of practitioners. Finally, the confusion and complexity that typifies diagnosis in chronic pain may justify the selective use of diagnostic blocks that make anatomic and physiologic sense, even if their validity is incompletely proved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009957     DOI: 10.1097/00000542-199701000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  18 in total

Review 1.  Drug infusions for the diagnosis and treatment of chronic pain.

Authors:  David A O'Gorman; Srinivasa N Raja
Journal:  Curr Pain Headache Rep       Date:  2002-12

2.  Frontal plane dynamics of the centre of mass during quadrupedal locomotion on a split-belt treadmill.

Authors:  E M Latash; W H Barnett; H Park; J M Rider; A N Klishko; B I Prilutsky; Y I Molkov
Journal:  J R Soc Interface       Date:  2020-09-09       Impact factor: 4.118

3.  Lidocaine treatment during synapse reformation periods permanently inhibits NGF-induced excitation in an identified reconstructed synapse of Lymnaea stagnalis.

Authors:  Shin Onizuka; Seiji Shiraishi; Ryuuji Tamura; Tetsu Yonaha; Nobuko Oda; Yuko Kawasaki; Naweed I Syed; Tetsuro Shirasaka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2011-10-30       Impact factor: 2.078

Review 4.  [Facet blockade, peridural and periradicular pain therapy].

Authors:  T Waggershauser; S Schwarzkopf; M Reiser
Journal:  Radiologe       Date:  2006-06       Impact factor: 0.635

Review 5.  Controversies surrounding reflex sympathetic dystrophy: a review article.

Authors:  R P Pawl
Journal:  Curr Rev Pain       Date:  2000

6.  Interventional pain medicine: retreat from the biopsychosocial model of pain.

Authors:  Randy S Roth; Michael E Geisser; David A Williams
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

7.  Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group.

Authors:  Steven P Cohen; Arun Bhaskar; Anuj Bhatia; Asokumar Buvanendran; Tim Deer; Shuchita Garg; W Michael Hooten; Robert W Hurley; David J Kennedy; Brian C McLean; Jee Youn Moon; Samer Narouze; Sanjog Pangarkar; David Anthony Provenzano; Richard Rauck; B Todd Sitzman; Matthew Smuck; Jan van Zundert; Kevin Vorenkamp; Mark S Wallace; Zirong Zhao
Journal:  Reg Anesth Pain Med       Date:  2020-04-03       Impact factor: 6.288

Review 8.  Local anaesthetic sympathetic blockade for complex regional pain syndrome.

Authors:  Neil E O'Connell; Benedict M Wand; William Gibson; Daniel B Carr; Frank Birklein; Tasha R Stanton
Journal:  Cochrane Database Syst Rev       Date:  2016-07-28

Review 9.  Cervicogenic headache: interventional, anesthetic, and ablative treatment.

Authors:  Steven B Silverman
Journal:  Curr Pain Headache Rep       Date:  2002-08

10.  CT-guided stellate ganglion blockade vs. radiofrequency neurolysis in the management of refractory type I complex regional pain syndrome of the upper limb.

Authors:  Adrian Kastler; Sébastien Aubry; Nicolas Sailley; Demosthene Michalakis; Gaye Siliman; Guillaume Gory; Jean-Louis Lajoie; Bruno Kastler
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.